TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 120nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 120nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 120nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 120nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 2.50E+3nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 3.80E+3nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 3.80E+3nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 1.80E+4nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 1.80E+4nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 2.70E+4nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 3.10E+4nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 4.80E+4nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 7.20E+4nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 7.30E+4nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 9.30E+4nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetSubstance-K receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [125I]-NKA substance P binding to human urinary bladder membrane protein (NK2)More data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [125I]- substance P binding to human astrocytoma cells (NK1)More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.120nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.150nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.190nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.190nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.220nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.260nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.280nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.310nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.350nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.350nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.370nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.380nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.410nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.430nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.440nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.460nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.480nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.510nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.520nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
Affinity DataIC50: 0.520nMAssay Description:Inhibition of Staphylococcus aureus PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled assayMore data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.540nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.660nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair
TargetPeptide deformylase(Streptococcus pneumoniae serotype 4 (strain ATCC B...)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Streptococcus pneumoniae PDF assessed as formate release from fMAS peptide substrate after 20 mins by formate dehydrogenase coupled ass...More data for this Ligand-Target Pair